School-Based Depression Prevention for Adolescents With ADHD (BEAMS)

December 20, 2023 updated by: University of Maryland, College Park
The purpose of this study is to develop a modified behavioral activation program in adolescents with ADHD to be implemented by school mental health providers in an urban, low-income school district. Subsequently the investigators will examine its effectiveness in reducing depressive symptoms and improving emotion regulation and reward responsivity, compared to usual care.

Study Overview

Detailed Description

Children with ADHD are at elevated risk for depression in adolescence and young adulthood, and this comorbidity is associated with far greater impairment than either disorder alone, including higher rates of inpatient hospitalization and increased risk for suicidal ideation and behavior. Despite these adverse outcomes, existing evidence-based interventions for ADHD have not demonstrated effects in reducing depressive symptoms nor do established depression prevention programs work as well for adolescents with ADHD. Reward responsivity (RR) and emotion regulation (ER) are two key factors demonstrated to mediate the association between ADHD and depression and are thus key targets for prevention. In an effort to address the gap between access and utilization of mental health care, which is especially stark among adolescents with ADHD, the investigators aim to develop and test a modified behavioral activation prevention program [Behaviorally Enhancing Adolescents' Mood in Schools (BEAM-S)] that incorporates modules to directly target these purported mechanisms. In line with the Deployment-Focused Model of Intervention Development and Testing, the investigators will develop a program that can be easily implemented and sustainable in the high school setting as delivered by school mental health staff that reduces depression and improves overall functioning in adolescents with ADHD, by way of improving RR and ER. As a first step, the investigators will conduct focus groups with community stakeholders (e.g., school mental health providers, school administration, adolescents, parents, teachers) to develop an acceptable and sustainable selected and indicated prevention program for school staff to utilize. The investigators will then initially train school staff to deliver this prevention program via to pilot the intervention for implementation of the prevention program in a case series to evaluate preliminary feasibility. The investigators will then conduct a stage 1 RCT with a hybrid-type 1 implementation effectiveness design in three high schools where adolescents will be randomized to either the BEAM-S condition (n= 54) or treatment as usual (n = 54). Finally, qualitative and quantitative data from aims 1-3 will be used to prepare final procedures for a future large-scale effectiveness trial R01 (aim 4).

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • College Park, Maryland, United States, 20742
        • University of Maryland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Enrolled in a participating Baltimore City Public High School
  • DSM-5 Diagnosis of attention-deficit/hyperactivity disorder (ADHD)
  • Depressive symptoms above T=65 on the Children's Depression Inventory (CDI)

Exclusion Criteria:

  • History of seizures or neurological problems
  • DSM-diagnosis of Pervasive Developmental Disorder
  • Full scale IQ below 70
  • Current depressive symptoms or active suicidality at severe levels where more intensive services would be warranted

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behaviorally Enhancing Adolescents' Mood in Schools (BEAMS)
8-session modified behavioral activation program
8-session modified behavioral activation intervention
Active Comparator: Usual Care
Referrals to usual care
Referral to school mental health provider, social worker, or community care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Children's Depression Inventory, 2nd Edition (CDI-2)
Time Frame: After the 8-week preventive intervention
Adolescent and parent reported depressive symptoms
After the 8-week preventive intervention
Children's Depression Inventory, 2nd Edition (CDI-2)
Time Frame: 4-week follow-up
Adolescent and parent reported depressive symptoms
4-week follow-up
Children's Depression Inventory, 2nd Edition (CDI-2)
Time Frame: 12-week follow-up
Adolescent and parent reported depressive symptoms
12-week follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Affective Reactivity Index
Time Frame: After the 8-week preventive intervention
Adolescent and parent reported irritability
After the 8-week preventive intervention
Affective Reactivity Index
Time Frame: 4-week follow-up
Adolescent and parent reported irritability
4-week follow-up
Affective Reactivity Index
Time Frame: 12-week follow-up
Adolescent and parent reported irritability
12-week follow-up
Suicide Behavior Questionnaire
Time Frame: After the 8-week preventive intervention
Adolescent reported suicidal thoughts and behaviors
After the 8-week preventive intervention
Suicide Behavior Questionnaire
Time Frame: 4-week follow-up
Adolescent reported suicidal thoughts and behaviors
4-week follow-up
Suicide Behavior Questionnaire
Time Frame: 12-week follow-up
Adolescent reported suicidal thoughts and behaviors
12-week follow-up
Emotion Regulation Checklist
Time Frame: After the 8-week preventive intervention
Parent reported emotion dysregulation
After the 8-week preventive intervention
Emotion Regulation Checklist
Time Frame: 4-week follow-up
Parent reported emotion dysregulation
4-week follow-up
Emotion Regulation Checklist
Time Frame: 12-week follow-up
Parent reported emotion dysregulation
12-week follow-up
Difficulties in Emotion Regulation
Time Frame: After the 8-week preventive intervention
Adolescent reported emotion dysregulation
After the 8-week preventive intervention
Difficulties in Emotion Regulation
Time Frame: 4-week follow-up
Adolescent reported emotion dysregulation
4-week follow-up
Difficulties in Emotion Regulation
Time Frame: 12-week follow-up
Adolescent reported emotion dysregulation
12-week follow-up
Mirror Tracing Persistence Task
Time Frame: After the 8-week preventive intervention
Emotion regulation behavioral task
After the 8-week preventive intervention
Mirror Tracing Persistence Task
Time Frame: 4-week follow-up
Emotion regulation behavioral task
4-week follow-up
Mirror Tracing Persistence Task
Time Frame: 12-week follow-up
Emotion regulation behavioral task
12-week follow-up
Tripartite Pleasure Inventory
Time Frame: After the 8-week preventive intervention
Adolescent reported reward responsiveness
After the 8-week preventive intervention
Tripartite Pleasure Inventory
Time Frame: 4-week follow-up
Adolescent reported reward responsiveness
4-week follow-up
Tripartite Pleasure Inventory
Time Frame: 12-week follow-up
Adolescent reported reward responsiveness
12-week follow-up
Reward Probability Index
Time Frame: After the 8-week preventive intervention
Measure of adolescent reported environmental reward
After the 8-week preventive intervention
Reward Probability Index
Time Frame: 4-week follow-up
Measure of adolescent reported environmental reward
4-week follow-up
Reward Probability Index
Time Frame: 12-week follow-up
Measure of adolescent reported environmental reward
12-week follow-up
Behavioral Activation for Depression Scale
Time Frame: After the 8-week preventive intervention
Adolescent reported measure of behavioral activation and avoidance
After the 8-week preventive intervention
Behavioral Activation for Depression Scale
Time Frame: 4-week follow-up
Adolescent reported measure of behavioral activation and avoidance
4-week follow-up
Behavioral Activation for Depression Scale
Time Frame: 12-week follow-up
Adolescent reported measure of behavioral activation and avoidance
12-week follow-up
Balloon Analog Risk Task
Time Frame: After the 8-week preventive intervention
Positive reinforcement
After the 8-week preventive intervention
Balloon Analog Risk Task
Time Frame: 4-week follow-up
Positive reinforcement
4-week follow-up
Balloon Analog Risk Task
Time Frame: 12-week follow-up
Positive reinforcement
12-week follow-up
Impairment Rating Scale
Time Frame: After the 8-week preventive intervention
Parent- and teacher- report of global impairment
After the 8-week preventive intervention
Impairment Rating Scale
Time Frame: 4-week follow-up
Parent- and teacher- report of global impairment
4-week follow-up
Impairment Rating Scale
Time Frame: 12-week follow-up
Parent- and teacher- report of global impairment
12-week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Meinzer, PhD, University of Maryland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 7, 2018

Primary Completion (Actual)

July 1, 2021

Study Completion (Actual)

July 11, 2022

Study Registration Dates

First Submitted

September 24, 2019

First Submitted That Met QC Criteria

September 24, 2019

First Posted (Actual)

September 26, 2019

Study Record Updates

Last Update Posted (Actual)

December 27, 2023

Last Update Submitted That Met QC Criteria

December 20, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depressive Symptoms

Subscribe